A regional health organisation wanted to use data and AI more effectively without separating technical performance from clinical accountability. Quality signals, claims pathways and model outputs were interpreted by different teams under different rules. Marketways framed the engagement around safe workflow use, clear escalation and evidence that a digital intervention improved the complete process.
The engagement objective
Through the initial discovery, Marketways defined the objective: coordinate data quality, risk detection, AI evaluation and accountable workflow use.
How Marketways translated the problem
We began with a practical question: Which patterns warrant clinical or operational review? The first analysis used incidents, outcomes, case mix, staffing, process measures and reviews.
That evidence could not be read in isolation. Coding changes, reporting behaviour and case mix can resemble a quality change. Headline accuracy does not establish subgroup safety, calibration or workflow benefit.
A model could predict a clinical event without showing that the proposed intervention would help. We kept prediction, treatment pathway and human clinical authority separate when translating the result into action.
We did not judge each component by its isolated KPI. We examined how people, assets, decisions and constraints affected one another, then used the evidence to test whether an apparent improvement would strengthen the complete system or merely move cost, pressure or risk elsewhere.
How the engagement developed
The initial work on quality and safety risk detection exposed dependencies with clinical ai evaluation and workflow fit, revenue-cycle and claims pathway. Treating them as separate recommendations would have left the operating trade-offs unresolved.
- Quality and safety risk detection: Find emerging risk without replacing professional judgement.
- Clinical AI evaluation and workflow fit: Set evidence, oversight and fallback requirements before reliance.
- Revenue-cycle and claims pathway: Improve collection and patient clarity while preserving compliant decisions.
Evidence we examined
- Incidents, outcomes, case mix, staffing, process measures and reviews.
- Representative cases, ground truth, subgroup data, overrides and outcomes.
- Claims, authorisations, coding, denials, documentation and payment.
Industry conditions we accounted for
- Coding changes, reporting behaviour and case mix can resemble a quality change.
- Headline accuracy does not establish subgroup safety, calibration or workflow benefit.
- Financial and clinical workflows share data but have different accountabilities.
How our engagement contributed to business impact
We connected every method to a decision and a business measure. The organisation could assess the engagement through operating results as well as model performance.
- Quality and safety risk detection
- Method: Statistics & Econometrics, Machine Learning & Predictive Analytics.
- Evidence: Incidents, outcomes, case mix, staffing, process measures and reviews.
- Decision supported: Find emerging risk without replacing professional judgement.
- Impact measure: Earlier review, preventable-event reduction and manageable alert burden.
- Clinical AI evaluation and workflow fit
- Method: Machine Learning & Predictive Analytics, Research & Evidence Collection.
- Evidence: Representative cases, ground truth, subgroup data, overrides and outcomes.
- Decision supported: Set evidence, oversight and fallback requirements before reliance.
- Impact measure: Task performance, subgroup reliability, override learning and patient impact.
- Revenue-cycle and claims pathway
- Method: Process, Workflow & Systems, Data Foundations & Business Intelligence.
- Evidence: Claims, authorisations, coding, denials, documentation and payment.
- Decision supported: Improve collection and patient clarity while preserving compliant decisions.
- Impact measure: Clean-claim rate, denial resolution, payment time and patient queries.
Implementation
The engagement was structured as controlled pilots and governance. We connected the analysis to the decisions, operating constraints and measures that the organisation would continue to use.
How success was assessed
The overall assessment considered useful detection, safe reliance and operational adoption. The supporting measures included:
- Earlier review, preventable-event reduction and manageable alert burden.
- Task performance, subgroup reliability, override learning and patient impact.
- Clean-claim rate, denial resolution, payment time and patient queries.
Services and methods used
Services: Risk Detection, Decision Assurance, AI & Model Risk, Process & Workflow Analysis & Redesign, Business Systems Design & Architecture.
Methods: Statistics & Econometrics, Machine Learning & Predictive Analytics, Research & Evidence Collection, Process, Workflow & Systems, Data Foundations & Business Intelligence.